Abeona Therapeutics Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ABEO Nasdaq 2836 www.abeonatherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Abeona Therapeutics Inc.

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Dec 31st, 2024 12:30 pm
Owning 43% shares,institutional owners seem interested in Abeona Therapeutics Inc. (NASDAQ:ABEO), - Dec 28th, 2024 1:38 pm
DealFlow Events Unveils First Wave of Companies for The Microcap Conference in January 2025 - Nov 27th, 2024 12:00 pm
ABEO: FDA Accepts BLA Re-Submission for Pz-cel; PDUFA Date of April 29, 2025; Raising Valuation to $9.50… - Nov 19th, 2024 11:10 am
Abeona Therapeutics Inc (ABEO) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Nov 15th, 2024 7:06 am
Abeona Therapeutics: Q3 Earnings Snapshot - Nov 14th, 2024 12:42 pm
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - Nov 14th, 2024 12:30 pm
Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa - Nov 12th, 2024 12:30 pm
Abeona Therapeutics® Announces Participation in November Investor Conferences - Nov 4th, 2024 12:30 pm
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration - Oct 29th, 2024 11:30 am
Abeona Therapeutics Inc (ABEO) Q2 2024 Earnings Call Highlights: Strong Financial Performance ... - Oct 9th, 2024 10:13 pm
Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - Sep 3rd, 2024 11:30 am
ABEO: Type A Meeting with FDA Concluded; BLA Submission on Track for 2H24… - Aug 14th, 2024 4:11 pm
Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - Aug 14th, 2024 11:30 am
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel - Aug 13th, 2024 11:30 am
Abeona Therapeutics: Q2 Earnings Snapshot - Aug 12th, 2024 11:37 am
Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission - Aug 12th, 2024 11:30 am
Institutional investors own a significant stake of 39% in Abeona Therapeutics Inc. (NASDAQ:ABEO) - Jul 21st, 2024 1:08 pm
Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications - Jul 11th, 2024 11:30 am
Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum - Jul 8th, 2024 11:30 am